The company has developed a dried blood spot sampling method that collects precise volumes of blood, enabling quantification of samples.
Capitainer hopes to change dried blood spot sampling with its proprietary qDBS (quantitative dried blood spot) sampling kit, which allows patients to produce quantifiable blood samples from the comfort of their own home.
DBS is an antiquated medical technology discovered in the 1910s, and first used widely in the 1960s. A patient pricks...
A deep-learning AI-based retinal image scanning tool can predict the risk of cardiovascular events over a 10-year period with 70% accuracy. The test is comparable to routine GP health checks, researchers from the University of Dundee have shown.
A recent FDA warning letter claims a Boston firm that specializes in wearable technology marketed a blood pressure device without agency approval. The company rejects the assertion and says the agency is out of step with federal law.
Waters Corp. will acquire Becton Dickinson’s Biosciences and Diagnostics business for $17.5bn, doubling its TAM to $40B. Analysts praise the flow cytometry addition but see weaker growth in diagnostics.
